BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18072719)

  • 1. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Park JJ; Pratt JM; Tweedale L; Kelland LR
    J Med Chem; 1999 Aug; 42(16):3167-74. PubMed ID: 10447962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
    J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
    Friebolin W; Schilling G; Zöller M; Amtmann E
    J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K; Grünert R; Bednarski PJ
    Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402.
    Zhang J; Wang X; Tu C; Lin J; Ding J; Lin L; Wang Z; He C; Yan C; You X; Guo Z
    J Med Chem; 2003 Jul; 46(16):3502-7. PubMed ID: 12877588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
    Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
    Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
    Dullin A; Dufrasne F; Gelbcke M; Gust R
    Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).
    Holford J; Raynaud F; Murrer BA; Grimaldi K; Hartley JA; Abrams M; Kelland LR
    Anticancer Drug Des; 1998 Jan; 13(1):1-18. PubMed ID: 9474239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
    Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
    Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro primary antitumor screen of imidazole platinum complexes.
    Kuduk-Jaworska J
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):77-82. PubMed ID: 7503641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.